Association driven by fewer major amputations ...

With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity ...

A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

Researchers developed a model using routine clinical data to identify optimal glucose-lowering therapies for patients with type 2 diabetes (T2D). Individuals receiving model-predicted optimal therapy ...

Explore the potential of SGLT2 inhibitors for IgAN. Learn how these diabetes drugs slow kidney damage progression when added to standard treatment.

A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving ...

One of the most commonly known oral T2 diabetes drugs out there, it’s been around for over two decades now and is often referred to as the “first line of defence” in treating type 2 diabetes.

These findings position henagliflozin at the intersection of diabetes care and longevity science. They are raising both optimism and debate over whether existing medications might also serve as ...